Cart
sales@molnova.com
VU6012962
CAS No. 2313526-86-0
VU6012962( —— )
Catalog No. M24054 CAS No. 2313526-86-0
VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 224 | In Stock |
|
| 50MG | 403 | In Stock |
|
| 100MG | 592 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVU6012962
-
NoteResearch use only, not for human use.
-
Brief DescriptionVU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).
-
DescriptionVU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).
-
In VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.
-
In VivoVU6012962 (1-10 mg/kg; i.p. injection; 60 minutes prior to testing) decreases anxiety in the elevated zero maze (EZM) assay in mice. Animal Model:C57Bl/6J male mice (8 weeks old)Dosage:1, 3, and 10 mg/kg Administration:I.p. injections; 60 minutes prior to testing Result:Increased total time spent in the open arms at a dose of 3 mg/kg. 10 mg/kg did cause a decrease in overall locomotion.
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptormGlu7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2313526-86-0
-
Formula Weight448.4
-
Molecular FormulaC21H19F3N4O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (278.77 mM; Need ultrasonic);H2O:< 0.1 mg/mL (insoluble)
-
SMILESCOC1=C(C=CC(=C1)C(=O)NC2=C(C=CC(=C2)OC(F)(F)F)N3C=NC=N3)OCC4CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Reed CW, et al. Discovery of an orally bioavailable and Central Nervous System (CNS) penetrant mGlu7 NegativeAllosteric Modulator (NAM) in vivo tool compound: N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962). J Med Chem. 2019 Jan 4.
molnova catalog
related products
-
gamma-DGG acetate(67...
gamma-DGG acetate(6729-55-1 free base) (γ-D-Glutamylglycine) is a competitive blocker of AMPA receptor.
-
Neferine
Neferine has anti-tumor activities , Metabolic activation mediated by CYP3A4 and GSH depletion enhanced Neferine-induced cytotoxicity.
-
GW791343 3HCl
GW791343 HCl is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.
